USPTO serial 79179755
PORTON BIOPHARMA
Reviewed by CopyMark Law Group
Reg. 5293334Status 404
- Filing date
- Status date
- Registration date
- Sep 26, 2017
- Examiner
- ROSENBLATT, ANNA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PORTON BIOPHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Julia C. Archer
Julia C. Archer Enns & Archer LLP939 Burke StreetWinston-Salem, NC 27101UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, biologics and biopharmaceuticals in the form of vaccines, blood products in the nature of red blood cells, platelets, blood plasma, and blood plasma derivatives, namely, albumin, immunoglobulins and immunomodulatory factors, therapeutic proteins, gene therapy products, namely, pharmaceutical preparations for gene delivery and gene transfer for the treatment of cancers and diseases affecting the immune system, and living tissue used to protect against infectious disease and to treat cancers, rheumatoid diseases and disorders, skin diseases and disorders, immune system diseases and disorders, anemia and diseases of the blood, gastrointestinal diseases and disorders, and neurological diseases and disorders; sanitary preparations for medical purposes; plasters for medical purposes as materials for dressings; disinfectants; preparations for destroying vermin; fungicides, herbicides; pharmaceutical preparations and substances in the nature of vaccines and blood products in the nature of red blood cells, platelets, blood plasma, and blood plasma derivatives, namely, albumin, immunoglobulins and immunomodulatory factors, therapeutic proteins, gene therapy products, namely, pharmaceutical preparations for gene delivery and gene transfer for the treatment of cancers and diseases affecting the immune system, and living tissue; injectable pharmaceutical compositions and preparations comprising compounds having asparaginase activity for treatment of leukaemia; pharmaceutical compositions and preparations for the treatment of leukaemia and malignant diseases in the blood forming organs | SECTION 71 - CANCELLED | — |
| 041 | Education, namely, providing conferences, seminars, workshops, training, and exhibitions in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals and their development and manufacture, and the distribution of course materials in connection therewith; arrangement of conferences for educational purposes; advice relating to medical training; advisory services relating to training; advisory services relating to education; arranging and conducting of workshops in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; conducting instructional courses in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; conducting of educational seminars relating to medical matters; training courses relating to medicine; training courses relating to science; medical education services, namely, providing continuing medical education courses; medical training and teaching; organisation of training courses in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; publication of books; writing of texts other than publicity texts; providing continuing dental education courses; providing continuing medical education courses; provision of educational information about medical education; provision of training in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; provision of training courses in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; provision of on-line electronic publications not downloadable from the Internet in the nature of newsletters, articles, e-books, and white papers in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; production of video-tapes for corporate use in corporate educational training; professional consultancy relating to education; publication of educational material in the nature of textbooks in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; training services for medical visitors in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; training services for nurses in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; training services relating to health and safety; arranging and conducting of workshops relating to biologics; arranging and conducting of workshops relating to biopharmaceuticals; arranging and conducting training relating to biologics; arranging and conducting training relating to biopharmaceuticals; arrangement of workshops for educational purposes in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PORTON BIOPHARMA LIMITED
- Other trademarks owned by PORTON BIOPHARMA LIMITED
- Other trademarks owned by PORTON BIOPHARMA LIMITED
- Other trademarks in Class 005
- Other trademarks in Class 041
- Similar marks named PORTON BIOPHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 29, 2024 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Apr 29, 2024 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Apr 29, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Apr 12, 2024 | C71T | CANCELLED SECTION 71 | — |
| Sep 26, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 26, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 27, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 27, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 26, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 26, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 11, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 11, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 8, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 21, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 21, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 21, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 5, 2017 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Jun 2, 2017 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| May 23, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 5, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| May 3, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 3, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 3, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 3, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 18, 2017 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Apr 18, 2017 | GNCF | CONTINUATION OF FINAL REFUSAL E-MAILED | — |
| Apr 18, 2017 | CNCF | ACTION CONTINUING A FINAL - COMPLETED | — |
| Feb 27, 2017 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Feb 27, 2017 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 7, 2017 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Dec 23, 2016 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Sep 2, 2016 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 2, 2016 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 2, 2016 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 12, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 12, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 29, 2016 | ALIE | ASSIGNED TO LIE | — |
| Jul 25, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 13, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 25, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 25, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 22, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 21, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 19, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 12, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 7, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 7, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 6, 2016 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jan 3, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |